Key result
A 56-year-old male with diffused hepatic angiosarcoma and Kasabach-Merritt syndrome died of tumor metastasis 2 months after liver transplantation, indicating extremely poor prognosis.
Why the study?
Hepatic angiosarcoma is a rare, highly aggressive malignant tumor with poor prognosis, and reports of diffused hepatic angiosarcoma accompanied by Kasabach-Merritt syndrome are scarce.
Design
Case report and literature review
Follow-up
2 months after operation
Authors
Loading...
Clinicians should consider hepatic angiosarcoma in coagulopathic liver lesions; extends sparse reports but remains hypothesis-generating.
Case Report (n=1)
Liver transplantation should not be considered in patients with hepatic angiosarcoma due to extremely poor prognosis and rapid metastasis.
Zhang et al. (2020) conducted a case report in Diffused hepatic angiosarcoma with Kasabach-Merritt syndrome (n=1). Liver transplantation was evaluated on Survival. A 56-year-old male with diffused hepatic angiosarcoma and Kasabach-Merritt syndrome died of tumor metastasis 2 months after liver transplantation, indicating extremely poor prognosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: